** Shares of Biotech firm Holista CollTech HCT.AX fall 20% to A$0.024, set for biggest one-day drop in four months
** Co says its appeal against damages totalling $2.1 mln for distribution agreement disputes with ProImmune was dismissed by the U.S. Court of Appeals
** Adds that it intends to "vigorously defend" any proceedings commenced in Australia, claiming the judgment was obtained by fraud due to ProImmune's false representations
** Stock slumped as much as 30% earlier in the day
** Over 295,000 shares change hands, 1.2x the 30-day avg
** Stock trims YTD gains to 84.6%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。